Apeiron RIA LLC Buys 56 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Apeiron RIA LLC grew its position in Mettler-Toledo International Inc. (NYSE:MTD) by 22.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 311 shares of the medical instruments supplier’s stock after acquiring an additional 56 shares during the period. Apeiron RIA LLC’s holdings in Mettler-Toledo International were worth $381,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Inspire Investing LLC raised its position in Mettler-Toledo International by 0.7% in the fourth quarter. Inspire Investing LLC now owns 2,058 shares of the medical instruments supplier’s stock valued at $2,518,000 after purchasing an additional 14 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Mettler-Toledo International by 458.2% in the fourth quarter. SG Americas Securities LLC now owns 6,911 shares of the medical instruments supplier’s stock valued at $8,457,000 after buying an additional 5,673 shares during the period. Eads & Heald Wealth Management raised its holdings in Mettler-Toledo International by 14.3% in the 4th quarter. Eads & Heald Wealth Management now owns 400 shares of the medical instruments supplier’s stock valued at $489,000 after buying an additional 50 shares during the last quarter. Simon Quick Advisors LLC acquired a new stake in Mettler-Toledo International during the 4th quarter worth approximately $206,000. Finally, Solidarity Wealth LLC grew its holdings in Mettler-Toledo International by 0.9% during the 4th quarter. Solidarity Wealth LLC now owns 4,599 shares of the medical instruments supplier’s stock worth $5,628,000 after acquiring an additional 40 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their target price for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Robert W. Baird decreased their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Finally, Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,351.25.

Insider Activity

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,335.76 on Friday. The company has a market cap of $28.18 billion, a P/E ratio of 36.01, a PEG ratio of 4.19 and a beta of 1.12. Mettler-Toledo International Inc. has a fifty-two week low of $1,133.46 and a fifty-two week high of $1,546.93. The stock has a 50 day simple moving average of $1,245.04 and a two-hundred day simple moving average of $1,343.30.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.